Cost ‐effectiveness of Interventional therapies for management of Treatment‐resistant hypertension: systematic review of pharmacoeconomic studies

ConclusionOverall cost ‐effectiveness of interventional therapies for treatment of TRH was inconclusive based on the current available evidence. Therefore, strong clinical trials and pharmacoeconomic evaluations from different perspectives in various candidate populations are needed to generate adequate clinical and cos t‐effectiveness evidence for using interventional therapies in treatment of treatment resistant hypertension.

Source: Journal of Pharmaceutical Health Services Research - September 2, 2020 Category: Drugs & Pharmacology Authors: Mende Sorato, Majid Davari, Abbas Kebriaeezadeh, Nasim Naderi, Nizal Sarrafzadegan, Tamiru Shibru, Shekoufeh Nikfar, Amanuel Godana Arero Tags: Review Source Type: research